PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Protein linked to therapy resistance in breast cancer

Berkeley lab researchers identify possible new oncogene and future therapy target

Protein linked to therapy resistance in breast cancer
2012-09-12
(Press-News.org) A gene that may possibly belong to an entire new family of oncogenes has been linked by researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) to the resistance of breast cancer to a well-regarded and widely used cancer therapy.

One of the world's leading breast cancer researchers, Mina Bissell, Distinguished Scientist with Berkeley Lab's Life Sciences Division, led a study in which a protein known as FAM83A was linked to resistance to the cancer drugs known as EGFR-TKIs (Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors). Not only may this discovery explain the clinical correlation between a high expression of FAM83A and a poor prognosis for breast cancer patients, it may also provide a new target for future therapies.

"Resistance to EGFR-TKIs has limited their use for breast cancer treatment and until now the mechanisms behind this resistance have largely been a mystery," Bissell says. "We've demonstrated, both in cultured cells and in mice, that FAM83A has oncogenic properties and when overexpressed in cancer cells confers EGFR-TKI resistance and promotes the proliferation and invasion of tumors."

Bissell is the corresponding author along with Saori Furuta, also with Berkeley Lab's Life Sciences Division, of a paper describing this research in the Journal of Clinical Investigation (JCI). The paper is titled "FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice." Other co-authors are Sun-Young Lee, Roland Meier, Marc Lenburg, Paraic Kenny and Ren Xu.

Therapeutic targeting of oncogenes can be an effective way to fight some cancers as evidenced in the successful use of EGFR-TKIs to fight lung cancer. However, EGFR-TKIs have not been effective for treating breast cancers. EGFR-TKIs work by blocking EGFR from adding a phosphate molecule to downstream signaling proteins, an action called phosphorylation that is a necessary step in the development of many types of cancer.

"We hypothesized that resistance to EGFR-TKIs originated, at least in part, from molecular alterations that activated phosphorylation signaling downstream of EGFRs," Furuta says.

Using a unique three-dimensional cell culture assay based on phenotypic reversion that was originally developed by Bissell and her research group, the co-authors of the JCI paper screened for genes involved in EGFR-TKI resistance in both normal and cancerous human breast cell lines. They found that, while normal human breast tissue doesn't produce FAM38A, the protein is highly expressed in cancerous tissue. This was true for every breast cancer cell line they examined, and was particularly pronounced in those cell lines that have been the most resistant to treatment with EGFR-TKIs. Further studies showed that FAM83A interacts with and causes phosphorylation of critical signaling proteins downstream of EGFRs, as the researchers hypothesized. This downstream phosphorylation would act to blunt or negate any therapeutic effects of EGFR-TKIs that took place further upstream.

The results of this research are consistent with clinical data showing that breast cancer patients with high levels of FAM83A have a significantly lower survival rate than patients with low levels of FAM83A. However, while Bissell, Furuta and their colleagues note that a number of questions about FAM83A and other members of the FAM83 protein family remain to be addressed, the importance of these proteins as potential drug targets for therapy seems clear.

"The beauty of this study is that it not only helps explain why some breast cancer patients are resistant to EGFR-TKIs, but it also reveals a whole new family of potential oncogenes that could be a target for all types of cancer, including breast cancer," Bissell says.

Bissell says the results of this study also demonstrate the potential of using 3D phenotypic reversion assays as a new path to the discovery of more effective therapeutic drugs.

"Our 3D phenotypic reversion assay revealed the malignant phenotype, something that could not have been done with a 2D assay," she says. "This is the first time we have used our assay to discover a potential target for cancer drugs, but it shows that an assay like ours can be a powerful tool for finding new targets and therapies."



INFORMATION:

This research was primarily supported by the DOE Office of Science and the National Cancer Institute.

Lawrence Berkeley National Laboratory addresses the world's most urgent scientific challenges by advancing sustainable energy, protecting human health, creating new materials, and revealing the origin and fate of the universe. Founded in 1931, Berkeley Lab's scientific expertise has been recognized with 13 Nobel prizes. The University of California manages Berkeley Lab for the U.S. Department of Energy's Office of Science. For more, visit www.lbl.gov.

DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the Unites States, and is working to address some of the most pressing challenges of our time. For more information, please visit the Office of Science website at science.energy.gov.


[Attachments] See images for this press release:
Protein linked to therapy resistance in breast cancer

ELSE PRESS RELEASES FROM THIS DATE:

What are the effects of the Great Recession on local governments?

2012-09-12
Freezing positions and cutting workforces Trimming pension and health care costs and passing them to employees Lowering service delivery levels, but not imposing many new fees Using technology to reduce costs where possible Receiving added pressure but little help from States and the Federal Government This important new research sheds light on the challenges faced by city and county governments that must provide most basic services. Unlike federal or state governments, these local governments have limited ability to generate revenue and are often mandated to pay for ...

NASA infrared data reveals fading Tropical Storm Leslie and peanut-shaped Michael

NASA infrared data reveals fading Tropical Storm Leslie and peanut-shaped Michael
2012-09-12
When NASA's Aqua satellite passed over the Atlantic on Sept. 11 it caught Tropical Storm Leslie's clouds over Newfoundland and peanut-shaped Tropical Storm Michael to its southwest. The Atmospheric Infrared Sounder (AIRS) instrument captured infrared data on Tropical Storms Leslie and Michael when it passed overhead on Sept. 11. Michael Appears Peanut-Shaped on Satellite Imagery Tropical Storm Michael forecast to become a remnant low later today, Sept. 11, but as of 11 a.m. EDT Michael still had maximum sustained winds near 45 mph (75 kmh). It was located about 1,090 ...

Yellow lights mean drivers have to make right choice -- if they have time

Yellow lights mean drivers have to make right choice -- if they have time
2012-09-12
A couple of years ago, Hesham Rakha misjudged a yellow traffic light and entered an intersection just as the light turned red. A police officer handed him a ticket. "There are circumstances, as you approach a yellow light, where the decision is easy. If you are close to the intersection, you keep going. If you are far away, you stop. If you are almost at the intersection, you have to keep going because if you try to stop, you could cause a rear-end crash with the vehicle behind you and would be in the middle of the intersection anyway," said Rakha, professor of civil ...

Genetic make-up of children explains how they fight malaria infection

2012-09-12
Researchers from Sainte-Justine University Hospital Center and University of Montreal have identified several novel genes that make some children more efficient than others in the way their immune system responds to malaria infection. This world-first in integrative efforts to track down genes predisposing to specific immune responses to malaria and ultimately to identify the most suitable targets for vaccines or treatments was published in the Proceedings of the National Academy of Sciences by lead author Dr. Youssef Idaghdour and senior author Pr. Philip Awadalla, whose ...

Scientists discover how the brain ages

2012-09-12
The ageing process has its roots deep within the cells and molecules that make up our bodies. Experts have previously identified the molecular pathway that react to cell damage and stems the cell's ability to divide, known as cell senescence. However, in cells that do not have this ability to divide, such as neurons in the brain and elsewhere, little was understood of the ageing process. Now a team of scientists at Newcastle University, led by Professor Thomas von Zglinicki have shown that these cells follow the same pathway. This challenges previous assumptions ...

Uncertain about health outcomes, male stroke survivors more likely to suffer depression than females

2012-09-12
Philadelphia, PA, September 12, 2012 – Post-stroke depression is a major issue affecting approximately 33% of stroke survivors. A new study published in the current issue of Archives of Physical Medicine and Rehabilitation reports that the level to which survivors are uncertain about the outcome of their illness is strongly linked to depression. The relationship is more pronounced for men than for women. "Male stroke survivors in the US who subscribe to traditional health-related beliefs may be accustomed to, and value highly, being in control of their health," says ...

Information theory helps unravel DNA's genetic code

2012-09-12
DNA consists of regions called exons, which code for the synthesis of proteins, interspersed with noncoding regions called introns. Being able to predict the different regions in a new and unannotated genome is one of the biggest challenges facing biologists today. Now researchers at the Indian Institute of Technology in Delhi have used techniques from information theory to identify DNA introns and exons an order of magnitude faster than previously developed methods. The researchers were able to achieve this breakthrough in speed by looking at how electrical charges are ...

Going with the flow

2012-09-12
Scientists who study tissue engineering and test new drugs often need to sort, rotate, move, and otherwise manipulate individual cells. They can do this by prodding the cells into place with a mechanical probe or coaxing them in the desired direction with acoustic waves, electric fields, or flowing fluids. Techniques that rely on direct physical contact can position individual cells with a high level of precision while non-contact techniques are often faster for sorting large numbers of cells. An international team of researchers has now developed a way to manipulate cells ...

Less wear, longer life for memory storage device

2012-09-12
Probe storage devices read and write data by making nanoscale marks on a surface through physical contact. The technology may one day extend the data density limits of conventional magnetic and optical storage, but current probes have limited lifespans due to mechanical wear. A research team, led by Intel Corp., has now developed a long-lasting ultrahigh-density probe storage device by coating the tips of the probes with a thin metal film. The team's device features an array of 5,000 ultrasharp probes that is integrated with on-chip electronic circuits. The probes write ...

Weizmann Institute's mathematical model may lead to safer chemotherapy

2012-09-12
Cancer chemotherapy can be a life-saver, but it is fraught with severe side effects, among them an increased risk of infection. Until now, the major criterion for assessing this risk has been the blood cell count: if the number of white blood cells falls below a critical threshold, the risk of infection is thought to be high. A new model built by Weizmann Institute mathematicians in collaboration with physicians from the Meir Medical Center in Kfar Saba and from the Hoffmann-La Roche research center in Basel, Switzerland, suggests that for proper risk assessment, it is ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Protein linked to therapy resistance in breast cancer
Berkeley lab researchers identify possible new oncogene and future therapy target